Sign in
4

Changes in Ownership

Denali Therapeutics Inc. Filed Acc 0001714899-24-000194

Chief Medical Officer sold 22,458 shares at an average $24.49 ($549,928)

  • Traded under a Rule 10b5-1 plan

From the SEC's structured data for this filing

Trades in this filing

Table I: Non-derivative

Insider Date Transaction Shares Price Value Owned after D/I
Ho Carole Chief Medical Officer 2024-08-20 Sale 10b5-1 −2,453 $23.79 $58,357 138,815 D: show line 1 in the form
Ho Carole Chief Medical Officer 2024-08-21 Sale 10b5-1 −14,098 $24.41 $344,132 124,717 D: show line 2 in the form
Ho Carole Chief Medical Officer 2024-08-21 Sale 10b5-1 −5,907 $24.96 $147,439 118,810 D: show line 3 in the form
Open-market sales · 22,458 sh · avg $24.49 · $549,928
Loading xslF345X05/wk-form4_1724357642.xml…